Skip to main content

Table 1 Patients’ characteristics of included studies

From: Gabapentin as an adjuvant therapy to splinting in carpal tunnel syndrome (CTS): a systematic review and meta-analysis of randomized controlled trials

Study

Sample size

Age, (year)a

Malesb

Duration of symptomsa

Dominant hand, Rt-Ltb

Involved had, Rt-Ltb

Follow up, months

Intervention

Control

Intervention

Control

Intervention

Control

Intervention

Control

Intervention

Control

Intervention

Control

Eftekharsadat et al. [9] (100 mg)

30

15

42.46 (8.16)

46.34 (8.08)

6 (20)

2 (6.67)

21.56 (7.34)

21.33 (7.45)

28–2 (93.3–6.7)

27–3 (90–10)

18–12 (60–40)

19–11 (63.3–36.7)

2

Eftekharsadat et al. [9] (300 mg)

30

15

44.56 (8.58)

46.34 (8.08)

9 (30)

3 (10)

20.32 (7.93)

21.33 (7.45)

23–7 (76.7–23.3)

27–3 (90–10)

18–12 (60–40)

19–11 (63.3–36.7)

2

Hesami et al. [10] (300 mg)

23

20

41.04 (8.46)

48.30 (9.96)

0 (0)

4 (20)

ND

ND

ND

ND

ND

ND

1

Mehmetoglu et al. [11] (1800 mg)

28

30

47.125 (3.107)

47.8 (4.66)

2 (7.14)

6 (20)

18.75 (5.22)

24

(4.5)

28–0 (100–0)

24–6 (80–20)

15–13 (53.6–46.4)

15–15 (50–50)

6

  1. aData are presented as mean (standard deviation)
  2. bData are presented as No. (%)
  3. ND not defined